CORT
Corcept Therapeutics Inc Earnings
$73.23
Earnings Summary
Revenue | $181.89Mn |
Net Profits | $30.75Mn |
Net Profit Margins | 16.9% |
Corcept Therapeutics Inc’s revenue jumped 34.33% since last year same period to $181.89Mn in the Q4 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -0.36% fall in its revenue since last 3-months.
Corcept Therapeutics Inc’s net profit fell -1.94% since last year same period to $30.75Mn in the Q4 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -34.15% fall in its net profits since last 3-months.
Corcept Therapeutics Inc’s net profit margin fell -27% since last year same period to 16.9% in the Q4 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -33.91% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.42 |
EPS Estimate Current Year | 0.42 |
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.42 - a 51.18% jump from last quarter’s estimates.
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.42.
Key Ratios
Earning Per Share (EPS) | 0.26 |
Corcept Therapeutics Inc’s earning per share (EPS) fell -7.14% since last year same period to 0.26 in the Q4 2024. This indicates that the Corcept Therapeutics Inc has generated -7.14% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-10-30 | 0.28 | 0.41 | 46.43% |
2024-07-29 | 0.23 | 0.32 | 39.13% |
2025-02-26 | 0.42 | 0.26 | -38.58% |
2024-05-01 | 0.22 | 0.25 | 13.64% |
